Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Delving into the phase 2 ARGO clinical trial data presented at ACR 50 on Moonlake Therapeutics' Nanobody (sonelokimab) for treating active psoriatic arthritis.

Ticker(s): MLTX

Who's the expert?

Institution: Mayo Clinic

Rheumatologists at the Mayo Clinic in Jacksonville Florida with a treatment focus on Vasculitis, Behcets, Rheumatoid Arthritis, and Gout.
Currently manages 40 patients with rheumatoid arthritis and has read through the phase 1 early stage data regarding KPL-404.
Research focuses on Rheumatoid Arthritis, Lupus, and Vasculitis.

Interview Goal

This call will feature a discussion on the current standard of care and the potential of Nanobody (sonelokimab) from MoonLake Immunotherapeutics for the treatment of active psoriatic arthritis including an analysis of the phase 2 ARGO clinical trial data on Nanobody (sonelokimab) in active psoriatic arthritis presented at ACR 50.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.